Ibrutinib and Aspergillus: a Btk-targeted risk

Woyach JA. Ibrutinib and Aspergillus: a Btk-targeted risk.
Blood 132(18) 11/01/2018

Abstract

Ibrutinib and Aspergillus: a Btk-targeted risk
Full Text